UPM Institutional Repository

Granulab: commercializing GranuMas


Said, Mohd Fuaad and Adham, Khairul Akmaliah and Muhamad, Nursaadah and Md. Ramli, Raudha (2013) Granulab: commercializing GranuMas. Asian Journal of Case Research, 6 (2). pp. 73-92. ISSN 1985-4579


GranuLab Sdn. Bhd. (GranuLab) was formed in 2005 to host the development and commercialization of a patented synthetic bone graft substitute, made from limestone and pure chemicals, called GranuMaS. The GranuMaS technology was invented by a group of researchers, led by one from SIRIM. The research began in 2000, and in 2005, GranuLab founders identified a huge business opportunity for GranuMaS. They then developed the business opportunity, resulting in the transfer of GranuMaS technology to GranuLab, and in turn GranuLab being acquired by Sindora in mid-2007. By then, the founders had to think of its next course of action. But, they realized the need to first educate GranuLab’s parent company on managing a technology-based venture, particularly one that involved an invasive medical technology. This case describes the process of innovation of the medical technology, technology transfer, and entrepreneurship at GranuLab, leading to the commercialization of GranuMaS. It is designed to stimulate critical thinking of the process of innovation and entrepreneurship, and provide understanding of the process of a medical technology commercialization.

Download File

PDF (Abstract)

Download (147kB) | Preview

Additional Metadata

Item Type: Article
Divisions: Faculty of Economics and Management
Publisher: Universiti Putra Malaysia Press
Keywords: GranuLab; Synthetic bone graft substitute; GranuMaS; Medical devices; Innovation; Entrepreneurship; New venture life cycle; Malaysia
Depositing User: Nabilah Mustapa
Date Deposited: 04 Aug 2015 07:51
Last Modified: 30 Mar 2016 04:59
URI: http://psasir.upm.edu.my/id/eprint/28367
Statistic Details: View Download Statistic

Actions (login required)

View Item View Item